THE SMART TRICK OF API PRODUCTS THAT NOBODY IS DISCUSSING

“The existing situation has exposed some structural weaknesses within the EU’s medicines supply chain and also a superior dependence on non-EU countries for active pharmaceutical ingredients,” Kyriakides stated. She recommended that provide chain problems be addressed within an EU pharmaceutical system expected for being introduced by the top